Alzheimer's disease & dementia

Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug

A new Alzheimer's drug from Biogen brought in only $300,000 in sales during its first full quarter on the market, extending a slow debut complicated by coverage questions and doctor concerns.

Health

Is a combo COVID/flu shot on the way?

During the next few weeks or months, you might find yourself dropping by the doctor's office or pharmacy to get your annual flu shot along with a dose of COVID vaccine.

Oncology & Cancer

A new strategy to fight cancer: Silencing the silencer

A breakthrough in cancer treatment just nine years ago has brought new hope to millions of people whose cancers are resistant to all other therapies. The new treatment, cancer immunotherapy, frees the body's potent immune ...

page 1 from 40